Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Werewolf Therapeutics Inc (NASDAQ: HOWL) closed the day trading at $2.72 down -8.11% from the previous closing price of $2.96. In other words, the price has decreased by -$8.11 from its previous closing price. On the day, 0.86 million shares were traded. HOWL stock price reached its highest trading level at $2.96 during the session, while it also had its lowest trading level at $2.69.
Ratios:
For a better understanding of HOWL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.13 and its Current Ratio is at 12.13. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on April 03, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $12.
On August 24, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOWL now has a Market Capitalization of 129358304 and an Enterprise Value of 20242840. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.81 while its Price-to-Book (P/B) ratio in mrq is 1.14. Its current Enterprise Value per Revenue stands at 2.181 whereas that against EBITDA is -0.358.
Stock Price History:
Over the past 52 weeks, HOWL has reached a high of $8.19, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is 20.72%, while the 200-Day Moving Average is calculated to be -32.68%.
Shares Statistics:
Over the past 3-months, HOWL traded about 546.03K shares per day on average, while over the past 10 days, HOWL traded about 2729290 shares per day. A total of 39.11M shares are outstanding, with a floating share count of 30.40M. Insiders hold about 30.45% of the company’s shares, while institutions hold 58.46% stake in the company. Shares short for HOWL as of 1728950400 were 775986 with a Short Ratio of 1.42, compared to 1726185600 on 1115523. Therefore, it implies a Short% of Shares Outstanding of 775986 and a Short% of Float of 3.0299999.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 6.0 analysts currently analyzing and rating the stock of Werewolf Therapeutics Inc (HOWL).The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.31 and low estimates of -$0.83.
Analysts are recommending an EPS of between -$1.41 and -$2.07 for the fiscal current year, implying an average EPS of -$1.65. EPS for the following year is -$1.94, with 6.0 analysts recommending between -$1.03 and -$4.45.
